Open AccessEvaluation of the Impact of Metabolic Syndrome on Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease
Author(s) -
Haluk Tarık Kani,
Coşkun Özer Demirtaş,
Çağlayan Keklikkıran,
İlkay Ergenç,
Shahin Mehdiyev,
Esra Akdeniz,
Yusuf Yılmaz
Publication year - 2021
Publication title -
pubmed central
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.404
H-Index - 28
eISSN - 2148-5607
DOI - 10.5152/tjg.2021.20512
Subject(s) - medicine , metabolic syndrome , fatty liver , diabetes mellitus , body mass index , gastroenterology , fibrosis , nonalcoholic fatty liver disease , liver biopsy , hepatic fibrosis , univariate analysis , waist , disease , multivariate analysis , biopsy , endocrinology , obesity
Metabolic syndrome (MS) is a condition that consists of several disorders, and the individual impact of these disorders on metabolic dysfunction-associated fatty liver disease (MAFLD) is still not clear in a combined diagnosis of MS. In this study, we aimed to investigate the effect of MS on advanced fibrosis in patients with MAFLD.